"I want to ask about this, but I need to know if my insurance will pay for it before I get my hopes up."
If that sentence has been sitting in your throat, waiting for the right moment at your next appointment in St. Peters, this article is for you. It gives you words to use, in order, so the money question and the medical question both get answered in the same visit.
You are far from the only person who thinks this way. Among the 443 adults our ten-state Midwest poll reached, 65 percent put coverage in the deciding or big-factor tier for trying ketamine or esketamine for depression: 43 percent called it big and 22 percent said it would settle things outright. The numbers are final, and the point is plain: for most people, cost is part of the decision.
Why say it to your doctor at all
Raising cost is not a sign you are less serious. A plan that is medically ideal but financially impossible is not a plan.
There is another reason. Your doctor is the person you are most likely to listen to on this. Of the people we surveyed, 74 percent would try the treatment on their doctor's recommendation, and 56 percent would take the question to a primary doctor first. The conversation you are about to have is the one that actually moves the decision.
Before the appointment
Spend twenty minutes getting ready. Bring:
- Your insurance card, front and back.
- Your antidepressant history, with approximate dates and outcomes.
- Any notes from a call to your insurer, if you made one.
- One sentence about how you are actually doing right now, written down in case you freeze.
People often minimize in the exam room; a written sentence keeps you honest.
The script, in four parts
You do not need to read this word for word. Use it as a frame and put it in your own voice.
Part one: say where you are.
"The medication I am on is not doing enough. I have tried [number] different ones, and I am still [describe it: not sleeping, not enjoying anything, struggling at work]. I want to talk about what else might be out there."
Part two: name the option you have heard about.
"I came across Spravato, the esketamine nasal spray, and read that it is meant for depression the usual medicines have not fixed. Could it fit someone like me, or does something in my history rule it out?"
Asking it this way invites your doctor's honest judgment, including a no. Spravato is approved by the FDA for hard-to-treat depression, and every dose happens under watch at a certified site. It suits some people and not others, and your doctor may have reasons, based on your history, to suggest something else first.
Part three: raise the coverage question directly.
"Insurance is going to matter a lot in whether I can do this. I have [plan name]. Do you know if it usually covers esketamine, and would you be willing to help with a prior authorization if it comes to that?"
Many plans that cover esketamine require prior authorization, which usually includes a record of the medications you have already tried. Your doctor's documentation is often the core of that request. Asking them to help is not an imposition. It is a normal part of the process.
Part four: ask about logistics.
"If we go this direction, where would I actually go for it? Is there a certified site near St. Peters, and how often would I need to be there?"
This question is practical for a reason. An esketamine visit runs long, since the observation window lasts a couple of hours at minimum, and someone else must drive. Distance mattered to our respondents, too: 43 percent ranked nearness among their two chief concerns. Brain Recovery Centers keeps a plain guide to esketamine costs and coverage that pairs well with this question. Knowing how far you will travel, and who will drive, helps you judge whether a covered option is actually a workable one.
When the doctor is unfamiliar with it
That can happen, and it is not a failure on anyone's part. Esketamine is newer than most antidepressants, and many clinicians refer patients out for it rather than providing it. Public awareness is thin, too. Of those we polled, 73 percent did not recognize Spravato at all, and plenty of offices have yet to guide a patient through it.
If your doctor is unsure, you can ask, "Could you refer me to a psychiatrist or a clinic that can evaluate whether I am a candidate?" That keeps the door open without asking your doctor to become an expert on the spot.
If the insurance answer is messy
Coverage for supervised treatments can be split across benefits, and the first answer you get may be incomplete. In our poll, 51 percent would put up with insurance steps; cash for simplicity drew 23 percent, and another 26 percent had not made up their minds. If you are undecided too, say so. Your doctor or the treatment site can often explain what the out-of-pocket path would look like next to the covered one, so you are comparing real options instead of guesses.
What to leave with
Before the visit ends, try to walk out with at least one of these:
- A clear answer on whether esketamine is a reasonable option for you.
- A referral, or the name of a place to call.
- Clarity on who files any prior authorization.
- A follow-up date.
Consider this a conversation aid rather than medical advice. Outcomes are never certain with any treatment, and fit is something you and your clinician settle together.
Thoughts of hurting yourself, or of not wanting to be here, need attention today, not at your next visit. Use 988, spoken or typed, and a Suicide and Crisis Lifeline counselor answers whenever you reach out. Say the same words to your doctor directly.
Methodology
St. Peters readers, here is the source: Pollfish survey 395586438, taken by consumer-panel members through June 23, 2026, with 443 completes. All were aged 18 to 64, living in Nebraska, Iowa, Missouri, Illinois, Oklahoma, Minnesota, Kansas, Indiana, Wisconsin or Ohio. Percentages are validated and final. Our publisher asked for the research and paid for all of it.